Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Tevogen Bio Holdings

Tracked across 2 events · 28 articles · First seen Feb 26, 2026 · Last active Mar 26, 2026

Sentiment
35
Attention
2
Events
2
Relationships
3
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
2 40
Business
Tevogen Bio Holdings provided a strategic update on its capital management, including its lead investor's commitment to maintain shareholdings and plans for limited share utilization. The company is also evaluating potential acquisitions and a special cash dividend, aiming to better reflect the value of its assets.
Mar 13, 2026 · 8 articles
2 30
Business
Tevogen Bio Holdings announced a non-binding Letter of Intent to evaluate a potential acquisition of a Contract research organization. This move aims to expand its clinical development capabilities and transition into a revenue-generating healthcare enterprise, potentially strengthening earnings visibility and supporting a more capital-efficient growth model.
Feb 26, 2026 · 20 articles
Ryan Saadi CEO Tevogen Bio Holdings Ryan Saadi is the Founder and CEO of Tevogen Bio Holdings.
Databricks client of Tevogen Bio Holdings Tevogen.AI utilizes cloud and data services from Databricks.
Manmohan Patel lead investor Tevogen Bio Holdings Manmohan Patel is the lead investor in Tevogen Bio Holdings, holding significant
NEWSDESK
Track Tevogen Bio Holdings live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.